Brent M. Hunter - Feb 27, 2022 Form 4 Insider Report for Codex DNA, Inc. (TBIO)

Role
Sr. Director Corp Controller
Signature
/s/ Jennifer McNealey, as Attorney-in-Fact
Stock symbol
TBIO
Transactions as of
Feb 27, 2022
Transactions value $
$0
Form type
4
Date filed
3/1/2022, 03:30 PM
Previous filing
Sep 7, 2021
Next filing
Jul 11, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TBIO Stock Option (right to buy) +Grant/Award $0 +13,500 $0.00 13,500 Feb 27, 2022 Common Stock 13,500 $10.20 Direct F1, F2

Explanation of Responses:

Id Content
F1 The exercise price is the closing price of the Issuer's Common stock on February 28, 2022, the first business day following the date of grant.
F2 Subject to the Reporting Person's continuing as a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable vesting date, twenty-five percent (25%) of the shares subject to the option shall vest on the one (1) year anniversary of the Vesting Commencement Date, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest in equal monthly installments on the same day of the month as the Vesting Commencement Date. "Vesting Commencement Date" shall mean February 27, 2022.